Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1301 - 1350 of 1560
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
GHDx Entry last modified on: Mar 14, 2022
High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey
GHDx Entry last modified on: Jan 18, 2024
A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan
GHDx Entry last modified on: May 12, 2022
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Dyspnoea, lung function and CT findings 3months after hospital admission for COVID-19
GHDx Entry last modified on: Apr 10, 2023
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea
GHDx Entry last modified on: Mar 14, 2022
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients
GHDx Entry last modified on: Apr 10, 2023
A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo, Brazil
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee
GHDx Entry last modified on: Jan 31, 2024
Logistics Workers Are a Key Factor for SARS-CoV-2 Spread in Brazilian Small Towns: Case-Control Study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Post COVID-19 sequelae: A prospective observational study from Northern India
GHDx Entry last modified on: Jan 31, 2024
Universal screening for SARS-CoV-2 infection among pregnant women at Elmhurst Hospital Center, Queens, New York
GHDx Entry last modified on: Jan 31, 2024
Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13062 positive pregnancies including 176 maternal deaths in Mexico
GHDx Entry last modified on: Apr 10, 2023
Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis
GHDx Entry last modified on: Apr 10, 2023
Prevalence and Neighborhood Geomapping of COVID-19 in an Underserved Chicago Pregnant Population
GHDx Entry last modified on: Apr 10, 2023
Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil
GHDx Entry last modified on: Mar 22, 2024
Natural history of long-COVID in a nationwide, population cohort study
GHDx Entry last modified on: Mar 22, 2024
One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Twelve-month follow-up after hospitalization for SARS-COV-2: Physiology improves, symptoms remain
GHDx Entry last modified on: Mar 22, 2024
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
GHDx Entry last modified on: Mar 22, 2024
2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository by Johns Hopkins CSSE 2020-2022
GHDx Entry last modified on: Jan 22, 2024
United States COVID Tracking Project API - Historic State Data 2020-2021
GHDx Entry last modified on: Aug 29, 2023
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
GHDx Entry last modified on: Mar 14, 2022
Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2
GHDx Entry last modified on: Mar 14, 2022
Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
GHDx Entry last modified on: Mar 14, 2022
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnant women: a report based on 116 cases
GHDx Entry last modified on: Jan 31, 2024
Update on clinical outcomes of women with COVID-19 during pregnancy
GHDx Entry last modified on: Jan 31, 2024
Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China
GHDx Entry last modified on: Mar 8, 2024
Testing of Patients and Support Persons for Coronavirus Disease 2019 (COVID-19) Infection Before Scheduled Deliveries
GHDx Entry last modified on: Jan 31, 2024
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
GHDx Entry last modified on: Jan 31, 2024
Brazil - Rio Grande do Norte COVID-19 Epidemiological Report 2021
Informe Epidemiológico Coronavírus (Covid-19)
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
A Single-centre Study of COVID-19 Antibody
GHDx Entry last modified on: Mar 14, 2022
Low seroprevalence of COVID-19 in Lao PDR, late 2020
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
GHDx Entry last modified on: Mar 14, 2022
Subscribe